<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04740385</url>
  </required_header>
  <id_info>
    <org_study_id>202101-2P-02002</org_study_id>
    <nct_id>NCT04740385</nct_id>
  </id_info>
  <brief_title>Role of Lung Ultrasound in Confirmation of Correct Double Lumen Endotracheal Tube Placement in Thoracic Surgeries</brief_title>
  <official_title>Role of Transthoracic Lung Ultrasound in Confirmation of Correct Double Lumen Endotracheal Tube</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Egypt</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to assess the efficacy of lung ultrasound versus conventional auscultation method and&#xD;
      fiberoptic bronchoscopy in confirmation of double lumen tube position&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Confirmation of double lumen tube position by auscultation followed fiberoptic bronchoscopy&#xD;
      then lung ultrasound. After double lumen intubation all patient tube position will be&#xD;
      confirmed using auscultation then fiberoptic bronchoscopy then lung ultrasound&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 3, 2021</start_date>
  <completion_date type="Anticipated">December 5, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sensitivity and specificity of lung ultrasound in confirmation of correct double lumen position</measure>
    <time_frame>5 minutes</time_frame>
    <description>real time visulaization of air entry to the lung</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>procedural time</measure>
    <time_frame>5 minutes</time_frame>
    <description>time taken to confirm tube position</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">37</enrollment>
  <condition>Diagnostic Accuracy</condition>
  <arm_group>
    <arm_group_label>Lung cancer patients</arm_group_label>
    <description>Correct position of double lumen endotracheal tube will be assessed using lung sonography, routine chest auscultation and fiberoptic brochoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lung auscultation</intervention_name>
    <description>auscultation of air entry through chest wal</description>
    <arm_group_label>Lung cancer patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fiberoptic bronchoscopy</intervention_name>
    <description>Checking correct double lumen position through direct vision using fiberoptic bronchoscopy</description>
    <arm_group_label>Lung cancer patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lung Ultrasound</intervention_name>
    <description>real time visualization of air entry to the lungs using trans-thoracic lung ultrasound</description>
    <arm_group_label>Lung cancer patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        lung cancer patients undergoing thoracic surgeries requiring double lumen intubation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients scheduled for surgeries under general anesthesia requiring double lumen&#xD;
             endotracheal intubation&#xD;
&#xD;
          -  ASA I-II&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient refusal&#xD;
&#xD;
          -  patients not meeting the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walaa Y Elsabeeny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Walaa Y Elsabeeny, MD</last_name>
    <phone>01007798466</phone>
    <phone_ext>002</phone_ext>
    <email>walaa.elsabeeny@nci.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of anesthesia and pain medicine. National Cancer Institute</name>
      <address>
        <city>Cairo</city>
        <zip>11796</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walaa Y Elsabeeny, MD</last_name>
      <phone>01007798466</phone>
      <phone_ext>+2</phone_ext>
      <email>Walaa.elsabeeny@nci.cu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Egypt</investigator_affiliation>
    <investigator_full_name>Walaa Youssef Elsabeeny</investigator_full_name>
    <investigator_title>Lecturer of anesthesia and pain management</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

